WHO
says its advisory committee looking at AstraZeneca vaccine issues
Send a link to a friend
[March 12, 2021]
GENEVA (Reuters) - A World Health
Organization expert advisory committee is currently looking at
AstraZeneca's COVID-19 vaccine after some countries paused distribution
of it, but there is no reason not to use it, a spokeswoman said on
Friday.
|
Health authorities in several countries including Denmark, Norway,
Iceland have suspended the use of AstraZeneca's vaccine following
reports of the formation of blood clots in some people who have been
vaccinated.
Margaret Harris told a briefing that it was an "excellent vaccine"
and that no causal relationship had been established between the
shot and the health problems reported, calling the pause in use "a
precautionary measure".
"It's very important to understand that, yes, we should continue to
be using the AstraZeneca vaccine. All that we look at is what we
always look at: Any safety signal must be investigated...," she
said.
[to top of second column] |
The WHO's global advisory
committee on vaccine safety is currently
reviewing the reports and will report on its
findings, she added, as it does with any safety
issues.
"It is very important we are hearing safety
signals because if we were not hearing about
safety signals that would suggest there is not
enough review and vigilance"," she said.
(Reporting by Emma Farge and Stephanie Nebehay;
Editing by Hugh Lawson)
[© 2021 Thomson Reuters. All rights
reserved.] Copyright 2021 Reuters. All rights reserved. This material may not be published,
broadcast, rewritten or redistributed.
Thompson Reuters is solely responsible for this content |